Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Scfa biotherapy delays diabetes in humanized gnotobiotic mice by remodeling mucosal homeostasis and metabolome
PMID: 3575154
Methylmercury chloride exposure affects oocyte maturation through AMPK/mTOR-Mediated mitochondrial autophagy
The Peptides mechanism of action involves stimulating the pituitary gland to release growth hormone, thereby encouraging cellular and tissue proliferation
Key Benefits: More physiologic growth hormone pulses Reduced risk of side effects Often used in combination with GHRP peptides (like Ipamorelin or GHRP-2) for synergistic release Flexible dosing (often 5 days/week) Half-Life: ~30 minutes to 2 hours , depending on formulation and injection site CJC-1295 With DAC: The Extended-Release Option When CJC-1295 is formulated with DAC , its half-life extends up to 8 days , allowing for once-weekly dosing
Existing orders are unaffected any order already placed will be fulfilled and shipped as normal
US$ 21.53
US$ 29.08
US$ 26.08
